As an essential inflammatory cytokine, IL-6 has been reported to be highly expressed in the serum and cerebrospinal fluid (CSF) of NMO patients, and IL-6 levels were positively associated with disease severity 19. The gene discussed is IL6; the disease is neuromyelitis optica.